ArticleUnited European gastroenterology journal2019
Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease.
Jurij Hanžel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it